The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2017

Filed:

Aug. 13, 2013
Applicants:

The United States of America As Represented BY the Secretary of the Department of Health and Human Services, Washington, DC (US);

Colorado Seminary, Which Owns and Operates the University of Denver, Denver, CO (US);

Inventors:

Eric Bergeron, Atlanta, GA (US);

Scott Dusan Pegan, Denver, CO (US);

Stuart T. Nichol, Atlanta, GA (US);

Michelle Kay Deaton, Denver, CO (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 39/12 (2006.01); C12Q 1/04 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); C12N 7/00 (2013.01); C12Q 1/04 (2013.01); A61K 2039/5254 (2013.01); C12N 2760/12034 (2013.01); G01N 2333/175 (2013.01);
Abstract

The genetically modified nairoviruses of this invention possesses a viral ovarian tumor protease with decreased ability to remove ubiquitin (Ub) and ISG15 tags that the human organism uses to label proteins for removal. Exemplary are Crimean-Congo hemorrhagic fever virus and Erve virus. Unlike complete knockout strains, the modified virus retains enough activity for replication in a human cell line. This creates an immunogenic and non-pathogenic virus that can be used as an effective live vaccine agent for prophylaxis and treatment.


Find Patent Forward Citations

Loading…